Forte Biosciences Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$18.22

-0.06 (-0.33%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target -56.3% upside

Low Target $5.39

Average Target $7.97

High Target $9.61

Current Price $18.22

Current
$18.22

Target
$7.97

$5.39 $7.97 avg $9.61

Scenario Analysis

Bear Case

$5.39

-70.4%

Low target

Base Case

$7.97

-56.3%

Avg target

Bull Case

$9.61

+-47.3%

High target

Risk/Reward

0.7x

Unfavorable

Price in Context

52-Week High

$35.80

-49.1% from high

52-Week Low

$9.10

+100.2% from low

Target vs 52W High

$7.97

-77.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%